Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.
Nov 1, 2023
0
43
In the late 1970s, the relationship between the c-Src gene and cancer was discovered. The first oncogene was identified. Since then, c-Src has been found to be overactivated in half of colon, liver, lung, breast, prostate ...
Oct 31, 2023
0
31
The SARS-CoV-2 virus responsible for COVID-19 can cause severe acute respiratory syndrome, contrasting with other coronaviruses that were known to cause mild seasonal colds prior to its emergence in 2019. This raises the ...
Oct 27, 2023
0
53
Researchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immune cell function, that could be exploited using new anti-cancer immunotherapies.
Oct 19, 2023
0
0
The scientific literature is clear: chronic stress experienced in childhood increases the risk of illness in adulthood—everything from obesity and cancer to dependence and depression.
Oct 10, 2023
0
1
A new research paper titled "Biomedical generative pre-trained based transformer language model for age-related disease target discovery" has been published in Aging.
Oct 4, 2023
0
1
Researchers at Vanderbilt-Ingram Cancer Center have discovered a drug target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
Oct 4, 2023
0
1
Drew Weissman's decades of research into mRNA technology paved the way for COVID-19 vaccines, finally earning a Nobel prize for the physician-scientist.
Oct 2, 2023
0
33
A special supplement to the Journal of Alzheimer's Disease presents insights and new directions in both basic and clinical research into neurodegenerative diseases. Because by 2050, the number of people suffering from brain ...
Sep 28, 2023
0
25
A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published ...
Sep 27, 2023
0
34
